Kyowa Hakko's Setria Glutathione debuts on Chilean market in Nutrapharm supplement
Key takeaways
- Chile’s health authority, SEREMI, has approved Setria, a patented, fermentation-derived form of reduced L-glutathione, for sale in the country.
- This approval marks the first time the ingredient has debuted in a finished product on the Chilean supplement market.
- Manufacturer Kyowa Hakko says the ingredient functions as an antioxidant to protect cells from toxins and replenish natural reserves depleted by aging, poor diet, or medication.

Kyowa Hakko’s Setria, a patented, fermentation-derived form of reduced L-glutathione, has been approved for sale in a finished supplement product in Chile. The nation’s health authority Secretaría Regional Ministerial (SEREMI) de Salud issued the approval, marking the ingredient’s first debut in a finished product on the market.
Developed by Nutrapharm, the finished supplement product contains 500 mg of Setria Glutathione. Kyowa Hakko, says the approval is a milestone for the ingredient, which it highlights as a clinically researched and patented antioxidant that supports cellular and mitochondrial health.
“Chile’s supplement market continues to mature, with growing consumer interest in evidence-based products that are backed up with science,” says Gerardo Sanchez, CEO of Nutrapharm.
Setria is already used in finished supplement products across North America, Europe, Asia, and other global regions where it appears in formulations targeting a broad array of health categories, including healthy aging, detoxification, women’s health, and sports nutrition.
“Our use of clinically researched Setria and the approval through SEREMI validates our commitment to quality and transparency,” says Carmen Rodriguez, Nutrapharm R&D Director. “This supplement offers meaningful benefits for modern life.”
Kyowa Hakko claims Setria Glutathione is a highly absorbable, fermented tripeptide that replenishes body reserves depleted by aging, poor diet, and medications.Antioxidant performance
According to Kyowa Hakko, glutathione is among the most important molecules in the body because it protects cells from the damaging effects of toxins and oxidative stress.
The company highlights that Setria Glutathione is a highly absorbable tripeptide manufactured using a fermentation process that can help replenish the body’s reserves that may be depleted through poor diet, pharmaceutical drugs, and the natural aging process.
The supplier also offers Setria for Sport, which is a combination of Setria Glutathione (200 mg) and L-citrulline (2 g) backed by research suggesting it may help support and sustain nitric oxide production post-workout. According to the company, sustained nitric oxide levels may lead to reduced fatigue and may support recovery.
In other recent developments around Kyowa Hakko product development, the company spotlighted citicoline’s benefits for cognitive performance and long-term brain health through multiple complementary mechanisms.













